Catalog No.
PVV24601
Species reactivity
Lake Victoria marburgvirus (strain Musoke-80) (MARV) (Marburg virus (strain Kenya/Musoke/1980))
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant MARV VP40/Marburg VP40 (Met1-Val303).
Tested applications
ELISA: 1:4000-1:8000, WB: 1:1000-1:4000
Target
Matrix protein VP40, Marburg VP40, mVP40, Membrane-associated protein VP40, VP40
Purification
Purified by antigen affinity column.
Accession
P35260
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Ebola and Marburg viruses IgG detections in small ruminants and dogs from villages within outbreak areas in Gabon., PMID:40043032
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design., PMID:39285186
Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines., PMID:39217415
Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection., PMID:32922962
Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors., PMID:30107445
Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in mice., PMID:29070075
Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging., PMID:29021793
Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques., PMID:28402024
Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses., PMID:27335383
Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)., PMID:27070636
Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein., PMID:25514232
Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays., PMID:25230936
Marburg virus evades interferon responses by a mechanism distinct from ebola virus., PMID:20084112
Establishment and application of an infectious virus-like particle system for Marburg virus., PMID:20071483
Discovery of common marburgvirus protective epitopes in a BALB/c mouse model., PMID:19712478
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses., PMID:18444889
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge., PMID:17940980
Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents., PMID:17940979
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections., PMID:15811650
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein., PMID:14734183
For research use only. Not for human or drug use.
